Estimating Symptoms and Clinical Signs Instead of Disorders: The Path Toward The Clinical Use of Voice and Speech Biomarkers In Psychiatry
Langue
EN
Communication dans un congrès
Ce document a été publié dans
ICASSP 2024 - 2024 IEEE International Conference on Acoustics, Speech and Signal Processing (ICASSP), 2024-04-14, Seoul. 2024p. 10606 – 10610
Résumé en anglais
Despite the continuous innovation in voice biomarkers domain for more than a decade and the apparent need for clinicians to have objective diagnostic tools, no device has yet been implemented in real clinical settings or ...Lire la suite >
Despite the continuous innovation in voice biomarkers domain for more than a decade and the apparent need for clinicians to have objective diagnostic tools, no device has yet been implemented in real clinical settings or widely adopted by clinicians. After giving a short overview of the literature, we argue that in addition to the factors usually mentioned in the literature (low performance, database sizes, transparency, etc.), an underestimated but crucial factor preventing the use of such systems is the therapeutic relationship. We also discuss the “objectivity” of such systems, and the place of diagnosis in clinical practice and its conceptual limitations. In order to shape useful and relevant voice biomarkers, we propose to estimate symptoms instead of diagnosis, and draw perspectives related to this paradigm, which will require databases annotated with patients’ symptoms rather than only their pathological status. © 2024 IEEE.< Réduire
Mots clés en anglais
Biomarkers
Diagnosis
Voice Biomarker
Psychiatry
Clinical Signs
Clinical Use
Clinical Usefulness
Continuous Innovation
Diagnosis Criteria
Diagnostics Tools
Epistemology
Symptoms (Signs)
Project ANR
Health, behaviors and autonomous digital technologies - ANR-22-PESN-0009
Santé Numérique en Société - ANR-22-PESN-0004
Santé Numérique en Société - ANR-22-PESN-0004